Q2 STOCKS TO BUY

Drug Data Deals a Blow to Catabasis Pharmaceuticals Inc (CATB)

Catabasis Pharmaceuticals Inc (CATB) short sellers are celebrating the stock's 26% plunge

Jun 8, 2016 at 2:07 PM
facebook X logo linkedin


Biotech Catabasis Pharmaceuticals Inc (NASDAQ:CATB) is getting crushed this afternoon, after the drugmaker's cholesterol drug failed in a mid-stage trial. At last check, the stock was down roughly 26% at $5.08, and earlier fell as far south as $4.78, putting CATB on track for its worst daily performance ever. This is business as usual for the shares, which have surrendered 36% of their value year-to-date.

CATB short sellers must be loving life right now. During the past two reporting periods, short interest on the stock spiked close to 15%. Now, 7.8% of CATB's float is sold short, which would take approximately four weeks to buy back, at the stock's typical trading levels. Of course, the shares are short-sale restricted today amid their steep sell-off.

On the other hand, it seems as though the brokerage crowd is beginning to sing a different tune. Heading into today, all three analysts tracking CATB had doled out "strong buy" recommendations. Plus, the stock's consensus 12-month price target stood at $21.50 -- record-high territory, and quadruple the shares' current perch.

Since the drug data was released, signs of pessimism have begun cropping up. Specifically, Catabasis Pharmaceuticals Inc (NASDAQ:CATB) has seen its price target cut at Wedbush (to $17), Citigroup (to $8), and Oppenheimer (to $23).

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter